Key statistics
On Monday, Novocure Ltd (038:DUS) closed at 11.50, 38.82% above the 52 week low of 8.28 set on Feb 10, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 11.31 |
|---|---|
| High | 11.50 |
| Low | 11.28 |
| Bid | 11.49 |
| Offer | 11.59 |
| Previous close | 11.43 |
| Average volume | 325.71 |
|---|---|
| Shares outstanding | 113.79m |
| Free float | 100.98m |
| P/E (TTM) | -- |
| Market cap | 1.56bn USD |
| EPS (TTM) | -1.61 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 18:30 GMT.
More ▼
Press releases
- Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
- Novocure to Participate in 2026 Leerink Global Healthcare Conference
- Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
- Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer)
- U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
- Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
- Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
More ▼
